@misc{indiciae1c2c3c14d38e, title = {Identification of potent inhibitors of JUN N-terminal kinases for treatment of endometriosis and associated pain}, author = {Madasu, Chandrashekhar [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] (ORCID:0000000221529689) and Sirupangi, Tirupataiah [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] (ORCID:0009000231908540) and Herrera, Genesis J. [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] and Bohren, Kurt M. [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] (ORCID:0000000231834118) and Sharma, Kiran L. [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] (ORCID:000000021988389X) and Tan, Zhi [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] and Ta, Hai Minh [Verna and Marrs McLean, Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine] (ORCID:0000000272986177) and Yuan, Fei [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] and Palaniappan, Murugesan [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] (ORCID:0000000349166565) and Clementi, Caterina [Celmatix Therapeutics] and Tang, Suni [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] and Unser, Anna Catherine [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] (ORCID:0009000146781469) and Wilkinson, Jennifer [Promega Corporation] (ORCID:000900021994715X) and Robers, Matthew B. [Promega Corporation] and Guan, Xiaoming [Department of Obstetrics and Gynecology, Baylor College of Medicine] (ORCID:0000000227444512) and Li, Feng [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] (ORCID:0000000296804614) and Kim, Choel [Center for Drug Discovery, Baylor College of Medicine; Verna and Marrs McLean, Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine] and Sankaran, Banumathi [Molecular Biophysics and Integrated Bioimaging, Berkeley Center for Structural Biology, Lawrence Berkeley National Laboratory] and Kommagani, Ramakrishna [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] and Chamakuri, Srinivas [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] and Young, Damian W. [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] and Biem, Piraye Y. [Celmatix Therapeutics] and Matzuk, Martin M. [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] (ORCID:0000000214458632) and Palmer, Stephen S. [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine; Celmatix Therapeutics] and Monsivais, Diana [Department of Pathology and Immunology, Baylor College of Medicine; Center for Drug Discovery, Baylor College of Medicine] (ORCID:0000000156606392)}, year = {2026}, doi = {10.1073/pnas.2607561123}, url = {https://www.osti.gov/biblio/3685152}, note = {Source identifier: 3685152} }